Interpharm Holdings, Inc.
Other OTCTotal Valuation
Interpharm Holdings, Inc. carries a market capitalization of 660.00, placing it among publicly traded companies globally. Its enterprise value stands at 38.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 660.00 |
| Enterprise Value | 38.77M |
Share Statistics
Interpharm Holdings, Inc. currently has 66.74M shares outstanding.
| Shares Outstanding | 66.74M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.00, and the price-to-book ratio stands at -0.01.
| PE Ratio | N/A |
| PS Ratio | 0.00 |
| PB Ratio | -0.01 |
| P/TBV Ratio | -0.05 |
| P/FCF Ratio | -0.02 |
| P/OCF Ratio | -0.01 |
Enterprise Valuation
| EV / Sales | 0.56 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Interpharm Holdings, Inc. maintains a current ratio of 0.62, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.62 |
| Quick Ratio | 0.31 |
| Debt / Equity | -726.83 |
| Debt / EBITDA | -2.35 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -44.00 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.19 |
Taxes
| Income Tax | 7.09M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Interpharm Holdings, Inc.'s stock has declined approximately -99.7561% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.7561% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Interpharm Holdings, Inc. generated 69.21M in revenue and converted that into -29.36M in net income, yielding earnings per share of -0.44. EBITDA reached -16.36M, while operating income came in at -19.71M.
| Revenue | 69.21M |
| Gross Profit | 12.00M |
| Operating Income | -19.71M |
| Pretax Income | -22.27M |
| Net Income | -29.36M |
| EBITDA | -16.36M |
| EBIT | -19.71M |
| Earnings Per Share (EPS) | -0.44 |
Balance Sheet
Interpharm Holdings, Inc. holds 41,000.00 in cash and equivalents against 38.47M in total debt, resulting in a net debt position of 38.43M. Total book value stands at -39.30M, with working capital of -16.63M providing operational flexibility.
| Cash & Cash Equivalents | 41,000.00 |
| Total Debt | 38.47M |
| Net Debt | 38.43M |
| Equity (Book Value) | -39.30M |
| Book Value Per Share | -0.59 |
| Working Capital | -16.63M |
Cash Flow
Interpharm Holdings, Inc. produced -21.74M in operating cash flow over the past twelve months. After subtracting -7.86M in capital expenditures, free cash flow totaled -29.61M - equivalent to -0.45 per share.
| Operating Cash Flow | -21.74M |
| Capital Expenditures | -7.86M |
| Free Cash Flow | -29.61M |
| FCF Per Share | -0.45 |
Margins
Interpharm Holdings, Inc. operates with a gross margin of 17.34, reflecting its pricing power and cost economics. The operating margin of -28.49 and net profit margin of -42.42 provide insight into operational efficiency.
| Gross Margin | 17.34 |
| Operating Margin | -28.49 |
| Pretax Margin | -32.17 |
| Profit Margin | -42.42 |
| EBITDA Margin | -23.64 |
Dividends & Yields
The company's payout ratio of 12.47 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 12.47 |
| Shareholder Yield | -8,078.45 |
| FCF Yield | -4,884.43 |
Stock Splits
Interpharm Holdings, Inc.'s most recent stock split took place on November 19, 1997 with a 5:1 split ratio.
| Last Split Date | 11/19/1997 |
| Split Ratio | 5:1 |
Scores
Interpharm Holdings, Inc. posts an Altman Z-Score of -1.11, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.11 |